Horizon Therapeutics Public Company Stock News

Healthcare > Drug Manufacturers - General

Buy HZNP

*Your capital is at risk

$116.30

+0 (+0%)

At Close: Jan 04, 2024

Horizon Therapeutics (NASDAQ:HZNP) Rating Increased to Strong-Buy at BidaskClub

07:28am, Saturday, 29'th Feb 2020

Horizon Therapeutics (NASDAQ:HZNP) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday, BidAskClub reports. S

Horizon and Willis Tower Elevate the Need for Rare Disease Innovation on Rare Disease Day

03:00pm, Friday, 28'th Feb 2020

Horizon Therapeutics (Nasdaq: HZNP) and Willis Towers Watson (Nasdaq: WLTW) are partnering with Willis Tower to light the antennas of the Willis Tower on Feb. 29 in recognition of Rare Disease Day and

Horizon Therapeutics plc Partners with EveryLife Foundation to Establish $1 Million #RAREis Scholarship for Adults with Rare Diseases

01:00pm, Friday, 28'th Feb 2020

Horizon Therapeutics plc (Nasdaq: HZNP) today announced a $1 million commitment over five years to establish the #RAREis scholarship, a program that w

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by